• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续性树脂血液灌流对暴发性肝衰竭的影响。

Effects of serial resin hemoperfusion in fulminant hepatic failure.

作者信息

Bihari D, Hughes R D, Gimson A E, Langley P G, Ede R J, Eder G, Williams R

出版信息

Int J Artif Organs. 1983 Nov;6(6):299-302.

PMID:6668092
Abstract

Resin hemoperfusion using an albumin coated Amberlite XAD-7 column was performed in 19 patients in coma due to fulminant hepatic failure. The procedure was clinically well tolerated, with good blood compatibility, platelet and white cell levels being 97.3 +/- SE 3.2% and 105 +/- 3.8% of the respective initial values after four hours hemoperfusion. No significant changes were observed in beta-thromboglobulin, screen filtration pressure, plasma electrolytes, calcium, protein or albumin. The total plasma bilirubin fell by a mean of 24 mumol/l, with a reduction in 21 of the 25 perfusions studied of up to 104 mumol/l during perfusion. Mean plasma levels of total bile acids were 137 +/- 19 mumol/l and 115 +/- 16 mumol/l respectively before and after four hours hemoperfusion. The amount of bile acids recovered by elution of the resin column was over three times greater than that apparent from the change in plasma levels. Column chromatography on Sephadex G-25 of material eluted from the resin column showed various peaks to be removed, including substances in the middle molecular weight range (1000-5000 daltons). Of the patients treated, eight (42%) survived to leave hospital.

摘要

对19例暴发性肝衰竭所致昏迷患者采用涂有白蛋白的Amberlite XAD - 7柱进行树脂血液灌流。该操作在临床上耐受性良好,血液相容性良好,血液灌流4小时后血小板和白细胞水平分别为各自初始值的97.3±标准误3.2%和105±3.8%。β - 血小板球蛋白、筛滤压、血浆电解质、钙、蛋白质或白蛋白均未观察到显著变化。血浆总胆红素平均下降24 μmol/l,在研究的25次灌流中有21次在灌流期间下降高达104 μmol/l。血液灌流4小时前后血浆总胆汁酸平均水平分别为137±19 μmol/l和115±16 μmol/l。通过树脂柱洗脱回收的胆汁酸量比血浆水平变化所显示的量大三倍多。对从树脂柱洗脱的物质进行Sephadex G - 25柱色谱分析显示有多个峰被去除,包括中等分子量范围(1000 - 5000道尔顿)的物质。接受治疗的患者中有8例(42%)存活出院。

相似文献

1
Effects of serial resin hemoperfusion in fulminant hepatic failure.连续性树脂血液灌流对暴发性肝衰竭的影响。
Int J Artif Organs. 1983 Nov;6(6):299-302.
2
Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part II: in vivo evaluation.用于急性肝衰竭血液灌流的白蛋白包被的Amberlite XAD-7树脂。第二部分:体内评估。
Artif Organs. 1979 Feb;3(1):23-6. doi: 10.1111/j.1525-1594.1979.tb03800.x.
3
Platelet function during haemoperfusion in acute liver failure.急性肝衰竭血液灌流期间的血小板功能
Int J Artif Organs. 1980 Jan;3(1):30-4.
4
The use of an in vitro haemoperfusion circuit to evaluate the blood compatibility of albumin-coated Amberlite XAD-7 resin.使用体外血液灌注回路评估白蛋白包被的Amberlite XAD-7树脂的血液相容性。
Int J Artif Organs. 1978 May;1(3):129-34.
5
Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
Artif Organs. 1984 May;8(2):174-8. doi: 10.1111/j.1525-1594.1984.tb04268.x.
6
Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part I: adsorption studies.用于急性肝衰竭血液灌流的白蛋白包被的Amberlite XAD-7树脂。第一部分:吸附研究。
Artif Organs. 1979 Feb;3(1):20-2. doi: 10.1111/j.1525-1594.1979.tb03799.x.
7
[New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
Nihon Geka Gakkai Zasshi. 1985 May;86(5):566-75.
8
Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".
Czech Med. 1990;13(1):34-7.
9
[Artificial liver support system: removal of bilirubin and bile acids by hemoperfusion with ionex-column].人工肝支持系统:离子交换柱血液灌流清除胆红素和胆汁酸
Nihon Geka Gakkai Zasshi. 1983 Jan;84(1):63-73.
10
Resin hemoperfusion in hepatic porphyrias.
Artif Organs. 1985 May;9(2):169-72. doi: 10.1111/j.1525-1594.1985.tb04369.x.

引用本文的文献

1
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.肝肾综合征:急性透析质量倡议 (ADQI) 第 8 次国际共识会议专家组报告。
Crit Care. 2012 Feb 9;16(1):R23. doi: 10.1186/cc11188.
2
Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.生物人工肝治疗严重肝衰竭的临床经验。一项I期临床试验。
Ann Surg. 1997 May;225(5):484-91; discussion 491-4. doi: 10.1097/00000658-199705000-00005.
3
Development of a hybrid bioartificial liver.
一种混合生物人工肝的研发。
Ann Surg. 1993 May;217(5):502-9; discussion 509-11. doi: 10.1097/00000658-199305010-00010.
4
A bioartificial liver to treat severe acute liver failure.一种用于治疗严重急性肝衰竭的生物人工肝。
Ann Surg. 1994 May;219(5):538-44; discussion 544-6. doi: 10.1097/00000658-199405000-00012.
5
Acute liver failure.急性肝衰竭
Gut. 1991 Sep;Suppl(Suppl):S86-91. doi: 10.1136/gut.32.suppl.s86.